1. Home
  2. PJT vs BLTE Comparison

PJT vs BLTE Comparison

Compare PJT & BLTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PJT Partners Inc.

PJT

PJT Partners Inc.

HOLD

Current Price

$188.59

Market Cap

4.4B

Sector

Finance

ML Signal

HOLD

Logo Belite Bio Inc

BLTE

Belite Bio Inc

HOLD

Current Price

$156.32

Market Cap

4.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PJT
BLTE
Founded
2014
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.4B
4.1B
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
PJT
BLTE
Price
$188.59
$156.32
Analyst Decision
Hold
Strong Buy
Analyst Count
3
7
Target Price
$191.00
$156.00
AVG Volume (30 Days)
199.5K
247.6K
Earning Date
02-03-2026
11-10-2025
Dividend Yield
0.53%
N/A
EPS Growth
72.84
N/A
EPS
6.53
N/A
Revenue
$1,657,789,000.00
N/A
Revenue This Year
$15.24
N/A
Revenue Next Year
$10.85
N/A
P/E Ratio
$28.79
N/A
Revenue Growth
23.30
N/A
52 Week Low
$119.76
$49.00
52 Week High
$190.28
$170.25

Technical Indicators

Market Signals
Indicator
PJT
BLTE
Relative Strength Index (RSI) 68.15 52.81
Support Level $174.06 $146.06
Resistance Level $183.12 $170.25
Average True Range (ATR) 5.16 8.27
MACD 1.21 -2.22
Stochastic Oscillator 93.18 34.98

Price Performance

Historical Comparison
PJT
BLTE

About PJT PJT Partners Inc.

PJT Partners Inc is an advisory-focused investment bank that offers a portfolio of advisory services designed to help its clients achieve their strategic objectives. The company delivers a range of strategic advisory, capital markets advisory, restructuring and special situations, and shareholder advisory services to corporations, financial sponsors, institutional investors, and governments around the world. It also provides private fund advisory and fundraising services for alternative investment strategies, including private equity, real estate, hedge funds, and private credit. The company generates its revenue from advisory fees, placement services and others. Geographically, It generates a majority of its revenue from the United States.

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.

Share on Social Networks: